Derfor kan børn, der modtager bløde kapsler have en højere eksponering (med forøget risiko for toksicitet) eller en mindre optimal eksponering (med risiko for utilstrækkelig effekt).
Therefore, children receiving soft capsules might have higher exposure (with the risk of increased toxicity) or suboptinal exposure (with the risk of insufficient efficacy).